Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LYEL

Lyell Immunopharma (LYEL)

Lyell Immunopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LYEL
DateTimeSourceHeadlineSymbolCompany
08/05/202406:05GlobeNewswire Inc.Lyell Immunopharma to Participate in BofA Securities Health Care ConferenceNASDAQ:LYELLyell Immunopharma Inc
06/05/202422:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LYELLyell Immunopharma Inc
06/05/202422:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYELLyell Immunopharma Inc
06/05/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
06/05/202422:00GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024NASDAQ:LYELLyell Immunopharma Inc
06/03/202408:30GlobeNewswire Inc.Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual MeetingNASDAQ:LYELLyell Immunopharma Inc
29/02/202408:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
29/02/202408:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023NASDAQ:LYELLyell Immunopharma Inc
27/02/202408:05GlobeNewswire Inc.Lyell Immunopharma Announces Participation in March Investor ConferencesNASDAQ:LYELLyell Immunopharma Inc
14/02/202412:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
14/02/202412:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
14/02/202412:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
04/01/202408:05GlobeNewswire Inc.Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LYELLyell Immunopharma Inc
21/11/202312:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
21/11/202312:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
21/11/202312:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LYELLyell Immunopharma Inc
21/11/202308:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
10/11/202308:05GlobeNewswire Inc.Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of MelanomaNASDAQ:LYELLyell Immunopharma Inc
08/11/202308:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYELLyell Immunopharma Inc
08/11/202308:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
08/11/202308:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
01/11/202300:00GlobeNewswire Inc.Lyell Immunopharma Presentations at SITC Highlight New Nonclinical Data on Product Candidates and Innovative Technology to Shorten TIL ManufacturingNASDAQ:LYELLyell Immunopharma Inc
27/09/202323:00GlobeNewswire Inc.Lyell Immunopharma Announces the Acceptance of Six Abstracts for Presentation at 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:LYELLyell Immunopharma Inc
11/09/202323:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
11/09/202322:00PR Newswire (US)Cellares and Lyell to Evaluate Automated Manufacturing of Lyell's CAR T-Cell Therapy on Cellares' Cell Shuttle PlatformNASDAQ:LYELLyell Immunopharma Inc
11/09/202322:00GlobeNewswire Inc.Cellares and Lyell to Evaluate Automated Manufacturing of Lyell’s CAR T-Cell Therapy on Cellares’ Cell Shuttle PlatformNASDAQ:LYELLyell Immunopharma Inc
01/09/202306:05GlobeNewswire Inc.Lyell Immunopharma to Participate in Upcoming Investor ConferencesNASDAQ:LYELLyell Immunopharma Inc
09/08/202306:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LYELLyell Immunopharma Inc
09/08/202306:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LYELLyell Immunopharma Inc
09/08/202306:05GlobeNewswire Inc.Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023NASDAQ:LYELLyell Immunopharma Inc
 Showing the most relevant articles for your search:NASDAQ:LYEL